Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

diclofenac diethylammonium

Known as: Benzeneacetic Acid, 2-((2,6-Dichlorophenyl)Amino)-, Compd. with N-Ethylethanamine (1:1), DICLOFENAC DIETHYLAMINE, Diclofenac Diethylamine Salt 
 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

DiclofenacDiethylamines
Diclofenac Sodium 0.01 MG/MG Topical Gelanalogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Nano-transfersomes as a novel carrier for transdermal delivery.
The aim of this study was to design and optimize a nano-transfersomes of Diclofenac diethylamine (DDEA) and Curcumin (CRM). A 3(3… Expand
  • table 1
  • table 2
  • table 4
  • table 5
  • figure 1
Highly Cited
2012
Highly Cited
2012
S-Nitrosylation Inhibits Pannexin 1 Channel Function*
Background: Pannexin 1 contains multiple cysteine residues and is highly expressed in cell types rich in nitric oxide species… Expand
Highly Cited
2008
Highly Cited
2008
Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium.
The objective of this study was to develop a novel elastic bilayer vesicle entrapped with the non-steroidal anti-inflammatory… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Highly Cited
2006
Highly Cited
2006
An investigation into the characteristics and drug release properties of multiple W/O/W emulsion systems containing low concentration of lipophilic polymeric emulsifier.
Multiple W/O/W emulsions with high content of inner phase (Phi1=Phi2=0.8) were prepared using relatively low concentrations of… Expand
Highly Cited
2005
Highly Cited
2005
Efficacy of topical diclofenac diethylamine gel in osteoarthritis of the knee.
OBJECTIVE To assess the efficacy and safety of topical diclofenac diethylamine gel, 1.16%, 4 g applied qid for 3 weeks to relieve… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Highly Cited
2005
Highly Cited
2005
In vitro release of diclofenac diethylamine from caprylocaproyl macrogolglycerides based microemulsions.
The purpose of the present study was to determine the influence of both formulation parameters and vehicle structure on in vitro… Expand
2005
2005
Sorbitan Monolaurate 20 as a Potential Skin Permeation Enhancer in Transdermal Patches
The objective of our present work was to prepare transdermal matrix patches containing the drug,diclofenac diethy- lamine with… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Highly Cited
2004
Highly Cited
2004
Characterization of caprylocaproyl macrogolglycerides based microemulsion drug delivery vehicles for an amphiphilic drug.
Microemulsion systems composed of water, isopropyl myristate, PEG-8 caprylic/capric glycerides (Labrasol), and polyglyceryl-6… Expand
Highly Cited
2002
Highly Cited
2002
Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt.
In this study, matrix-type transdermal patches containing diclofenac diethylamine were prepared using different ratios of… Expand
  • table 1
  • figure 1
  • figure 1
  • figure 2
  • figure 3
Highly Cited
2002
Highly Cited
2002
In-vitro release of diclofenac diethylammonium from lipid-based formulations.
This article presents the preparation and topical performance of some new lipid-based formulations of diclofenac, namely (a) a… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE